跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RIVA-DAPSONE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
RIVA-DAPSONE
Authorized
STANDARD
RIVA-DAPSONE
laboratoire riva inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e4f6c68795954a38
Company
laboratoire riva inc.
Type
Standard
Approval Details
Approval Id
e4f6c68795954a38
Drug Approval Canada Name
RIVA-DAPSONE
Product Name
RIVA-DAPSONE
Status
Dormant
Status Date
2024-07-22
Original Market Date
2019-08-21
Din
02489058
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:16.92
Atc Original
J04BA02 DAPSONE
Atc Name
j 04 ba 02
Aig Number
0106115001
Company Name
laboratoire riva inc.
Company Address
660 Boul. Industriel, Blainville, Quebec, Canada, J7C 3V4
Active Ingredients
DAPSONE
100 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e4f6c68795954a38
Type
Standard
Back to Health Canada Approvals